{{Rsnum
|rsid=485497
|Chromosome=3
|position=160001345
|Orientation=plus
|GMAF=0.4761
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=IL12A-AS1
|Gene_s=IL12A-AS1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 46.9 | 28.3
| HCB | 59.9 | 35.0 | 5.1
| JPT | 68.1 | 26.5 | 5.3
| YRI | 0.7 | 23.8 | 75.5
| ASW | 5.3 | 29.8 | 64.9
| CHB | 59.9 | 35.0 | 5.1
| CHD | 63.9 | 29.6 | 6.5
| GIH | 23.0 | 56.0 | 21.0
| LWK | 4.5 | 22.7 | 72.7
| MEX | 39.7 | 43.1 | 17.2
| MKK | 6.5 | 45.2 | 48.4
| TSI | 37.3 | 44.1 | 18.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=21418175
|Title=Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies
|OA=1
}}

{{PMID|19458352|OA=1
}} Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}